In: Nature communications, 2016, vol. 7, p. 13466
Neutralization of the common p40-subunit of IL-12/23 in psoriasis patients has led to a breakthrough in the management of moderate to severe disease. Aside from neutralizing IL-23, which is thought to be responsible for the curative effect, anti-p40 therapy also interferes with IL-12 signalling and type 1 immunity. Here we dissect the individual contribution of these two cytokines to the...
|
In: Journal of Molecular Medicine, 2006, vol. 84, no. 7, p. 532-543
|
In: Seminars in Immunopathology, 2009, vol. 31, no. 4, p. 479-495
|
In: European Heart Journal, 2014, vol. 35, no. 40, p. 2839-2848
|
In: European Heart Journal, 2011, vol. 32, no. 20, p. 2573-2584
|
In: European Heart Journal, 2010, vol. 31, no. 18, p. 2301-2309
|